| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H Wehr, M Bednarska-Makaruk, W Łojkowska, A Graban, D Hoffman-Zacharska, A Kuczyńska-Zardzewiały, J Mrugała, M Rodo, A Bochyńska, A Sułek, D Ryglewic. Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dementia and geriatric cognitive disorders. vol 22. issue 1. 2006-08-18. PMID:16645274. |
in 229 patients with dementia and in 144 control subjects, polymorphisms of apolipoprotein e (apoe), low-density-lipoprotein (ldl)-receptor-related protein, alpha(2)-macroglobulin, interleukin (il) 1beta, angiotensin-converting enzyme and of methylene tetrahydrofolate reductase genes were investigated. |
2006-08-18 |
2023-08-12 |
human |
| Yvonne Davidson, Linda Gibbons, Nitin Purandare, Jane Byrne, Jayne Hardicre, Joanne Wren, Antony Payton, Neil Pendleton, Michael Horan, Alistair Burns, David M A Man. Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dementia and geriatric cognitive disorders. vol 22. issue 1. 2006-08-18. PMID:16645276. |
the aim of the study was to investigate whether possession of the epsilon4 allelic form of the apolipoprotein e (apoe) gene increases the risk of developing vascular dementia (vad). |
2006-08-18 |
2023-08-12 |
Not clear |
| Francesco Panza, Alessia D'Introno, Anna Maria Colacicco, Cristiano Capurso, Angelo Del Parigi, Sabrina A Capurso, Richard J Caselli, Alberto Pilotto, Emanuele Scafato, Antonio Capurso, Vincenzo Solfrizz. Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiology of aging. vol 27. issue 7. 2006-07-27. PMID:16023766. |
furthermore, many of the risk factors for cerebrovascular disease (cvd) and vascular dementia (vad), including serum total cholesterol, hypertension, atherosclerosis, and apolipoprotein e (apoe) genotype have also been shown to increase the risk of ad. |
2006-07-27 |
2023-08-12 |
Not clear |
| Nathan Pankratz, Lisa Byder, Cheryl Halter, Alice Rudolph, Clifford W Shults, P Michael Conneally, Tatiana Foroud, William C Nichol. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Movement disorders : official journal of the Movement Disorder Society. vol 21. issue 1. 2006-07-03. PMID:16116614. |
apoe genotype, age of onset, disease duration, smoking history, and dementia status were collected for families with pd, yielding 324 caucasian families with complete information. |
2006-07-03 |
2023-08-12 |
human |
| Dong Young Lee, Jong Choul Youn, Il Han Choo, Ki Woong Kim, Jin Hyeong Jhoo, Yong Su Pak, Kwon Woo Suh, Jong Inn Wo. Combination of clinical and neuropsychologic information as a better predictor of the progression to Alzheimer disease in questionable dementia individuals. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 14. issue 2. 2006-05-11. PMID:16473977. |
this study aimed to examine the clinical outcomes of questionable dementia (qd) elderly subjects after three years of follow-up and to compare the ability of a standardized clinical assessment, neuropsychologic tests, the apoe genotyping, and possible combinations of these methods to predict their progression to alzheimer disease (ad). |
2006-05-11 |
2023-08-12 |
human |
| J Persson, J Lind, A Larsson, M Ingvar, M Cruts, C Van Broeckhoven, R Adolfsson, L-G Nilsson, L Nyber. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology. vol 66. issue 7. 2006-05-02. PMID:16606914. |
previous research has shown that polymorphisms of apolipoprotein e (apoe) represent genetic risk factors for dementia and for cognitive impairment in the elderly. |
2006-05-02 |
2023-08-12 |
Not clear |
| Pei-Ning Wang, Hsiu-Chih Liu, Ker-Neng Li. The MCI study in Taiwan. Acta neurologica Taiwanica. vol 15. issue 1. 2006-04-27. PMID:16599294. |
both of the poor cognitive performance and apoe epsilon4 allele were risk factors for progressing to dementia. |
2006-04-27 |
2023-08-12 |
human |
| T L Huang, P P Zandi, K L Tucker, A L Fitzpatrick, L H Kuller, L P Fried, G L Burke, M C Carlso. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology. vol 65. issue 9. 2006-04-12. PMID:16275829. |
benefits of fatty fish on dementia risk are stronger for those without apoe epsilon4. |
2006-04-12 |
2023-08-12 |
Not clear |
| T L Huang, P P Zandi, K L Tucker, A L Fitzpatrick, L H Kuller, L P Fried, G L Burke, M C Carlso. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology. vol 65. issue 9. 2006-04-12. PMID:16275829. |
to compare associations of lean fish vs fatty fish (tuna or other fish) intake with dementia, alzheimer disease (ad), and vascular dementia (vad) and in relation to apoe epsilon4 status in the cardiovascular health cognition study (chcs). |
2006-04-12 |
2023-08-12 |
Not clear |
| Oye Gureje, Adesola Ogunniyi, Olusegun Baiyewu, Brandon Price, Frederick W Unverzagt, Rebecca M Evans, Valerie Smith-Gamble, Kathleen A Lane, Sujuan Gao, Kathleen S Hall, Hugh C Hendrie, Jill R Murrel. APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Annals of neurology. vol 59. issue 1. 2006-03-23. PMID:16278853. |
in contrast with other populations, the apoe epsilon4 allele was not significantly associated with alzheimer's disease or dementia. |
2006-03-23 |
2023-08-12 |
Not clear |
| Tuomo Polvikoski, Raimo Sulkava, Sari Rastas, Annamaija Sutela, Leena Niinistö, Irma-Leena Notkola, Auli Verkkoniemi, Petteri Viramo, Kati Juva, Matti Halti. Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study. Neuroepidemiology. vol 26. issue 2. 2006-03-21. PMID:16352910. |
to evaluate the effect of medical record use on figures for the incidence of dementia and the effect of apolipoprotein e (apoe) polymorphism on this incidence and neuropathologically defined alzheimer's disease (ad) in very elderly individuals. |
2006-03-21 |
2023-08-12 |
Not clear |
| Sebastiaan Engelborghs, Bart Dermaut, Peter Mariën, Anoek Symons, Ellen Vloeberghs, Karen Maertens, Nore Somers, Johan Goeman, Rosa Rademakers, Marleen Van den Broeck, Barbara Pickut, Marc Cruts, Christine Van Broeckhoven, Peter P De Dey. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiology of aging. vol 27. issue 2. 2006-03-14. PMID:16399213. |
dose dependent effect of apoe epsilon4 on behavioral symptoms in frontal lobe dementia. |
2006-03-14 |
2023-08-12 |
Not clear |
| Sebastiaan Engelborghs, Bart Dermaut, Peter Mariën, Anoek Symons, Ellen Vloeberghs, Karen Maertens, Nore Somers, Johan Goeman, Rosa Rademakers, Marleen Van den Broeck, Barbara Pickut, Marc Cruts, Christine Van Broeckhoven, Peter P De Dey. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiology of aging. vol 27. issue 2. 2006-03-14. PMID:16399213. |
to determine whether apolipoprotein alleles (apoe) influence behavioral and psychological signs and symptoms of dementia (bpsd), we initiated a prospective, longitudinal study. |
2006-03-14 |
2023-08-12 |
Not clear |
| Xuemei Huang, Peter Chen, Daniel I Kaufer, Alexander I Tröster, Charles Pool. Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Archives of neurology. vol 63. issue 2. 2006-02-28. PMID:16476806. |
to understand the relationship of apolipoprotein e (apoe) polymorphism to dementia in parkinson disease (pd) because the apoe epsilon4 allele is linked to alzheimer disease. |
2006-02-28 |
2023-08-12 |
Not clear |
| R O'Hara, C M Schröder, H C Kraemer, N Kryla, C Cao, E Miller, A F Schatzberg, J A Yesavage, G M Murph. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers. Neurology. vol 65. issue 4. 2006-01-23. PMID:16116137. |
this is the first study to provide preliminary evidence for a negative interaction of apoe epsilon4 and osah on memory in older adults, which may have important implications for treating cognitive decline and delaying dementia onset. |
2006-01-23 |
2023-08-12 |
Not clear |
| C G Ballard, C M Morris, H Rao, J T O'Brien, R Barber, S Stephens, E Rowan, A Gibson, R N Kalaria, R A Kenn. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology. vol 63. issue 8. 2006-01-18. PMID:15505155. |
dementia is common post stroke, but the potential role of early cognitive impairment and apoe epsilon4 as risk factors is unclear. |
2006-01-18 |
2023-08-12 |
Not clear |
| Nicola T Lautenschlager, Leon Flicker, Samuel Vasikaran, Peter Leedman, Osvaldo P Almeid. Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 13. issue 8. 2006-01-11. PMID:16085790. |
the authors investigated the frequency distribution of well-established risk factors for dementia--high plasma homocysteine and the apolipoprotein e epsilon4 allele (apoe epsilon4)--among older women with subjective memory complaints (smc) but no cognitive impairment, and with mild cognitive impairment (mci). |
2006-01-11 |
2023-08-12 |
Not clear |
| M Tanskanen, P J Lindsberg, P J Tienari, T Polvikoski, R Sulkava, A Verkkoniemi, S Rastas, A Paetau, S Kiuru-Enar. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype. Neuropathology and applied neurobiology. vol 31. issue 6. 2006-01-10. PMID:16281907. |
our results demonstrate a strong association between caa and apoe epsilon4 as well as dementia and suggest that the contribution of caa to dementia is largely independent of apoe epsilon4. |
2006-01-10 |
2023-08-12 |
human |
| C Dufouil, F Richard, N Fiévet, J F Dartigues, K Ritchie, C Tzourio, P Amouyel, A Alpérovitc. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology. vol 64. issue 9. 2006-01-06. PMID:15883313. |
apoe genotype, cholesterol level, lipid-lowering treatment, and dementia: the three-city study. |
2006-01-06 |
2023-08-12 |
Not clear |
| C Dufouil, F Richard, N Fiévet, J F Dartigues, K Ritchie, C Tzourio, P Amouyel, A Alpérovitc. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology. vol 64. issue 9. 2006-01-06. PMID:15883313. |
to examine the association of plasma cholesterol levels, lipid-lowering agent (lla) intake, and apoe genotype with dementia prevalence. |
2006-01-06 |
2023-08-12 |
Not clear |